Bone Therapeutics completed recruitment for its ALLOB® allogeneic cell therapy Phase IIA spinal fusion study. The company will extend the trial to assess early onset of bone formation and fusion.
Since launch in 2009, SI-BONE’s iFuse Implant System® has been used in >20,000 procedures worldwide. The product was recently launched in Australia and New Zealand.
CoreLink commenced U.S. launch of Entasis™, reportedly the only sacroiliac joint fusion system that self-harvests bone graft while simultaneously compressing the joint.
First Ray received FDA 510(k) clearance for Stealth Staple™, an intraosseous small bone fixation system for the treatment of arthrodesis, osteotomies and bone fractures.
Stryker acquired Stanmore Implants Worldwide in an all-cash transaction for £35.6MM (~US $52MM). Stanmore Implants’ portfolio comprises patient-specific and off-the-shelf implant systems for limb salvage.
Intelligent Implant Systems received FDA 510(k) clearance to market 2-level components for the Revolution™ Spinal System, allowing for use in 2-level posterior thoracolumbar fusion.